Blog Archives

Blog

Innovating Sales & Marketing Digital Engagement for Pharma and Med Tech

The regulatory environment for Pharma and Med Tech creates business challenges for digital engagement. Many…

CertaraApril 21, 2023

Blog

Stepwise PIPs: A Solution for the Challenges of Pediatric Drug Development

Early paediatric investigation plan (PIP) submissions – an unnecessarily bitter medicine? In the European Union…

CertaraApril 14, 2023

Blog

Considerations for Pricing & Formulary Access for DRG-Funded Hospital Drugs

In the United States, treatments or medical services that require the patient be admitted into…

CertaraApril 6, 2023

Blog

Tips & Tricks for Optimizing Your Pharmacokinetic Modeling & Simulation

Learn how to streamline your PK/PD workflows with expert tips.

CertaraMarch 23, 2023

Blog

Leveraging AI to Accelerate Drug Discovery: Vyasa Joins Certara

Applying Vyasa’s deep learning expertise to Certara products will enable our clients to expand how…

CertaraMarch 10, 2023

Blog

Drug Development Considerations for Live Biotherapeutic Products

A new class of complex biologics has emerged in recent years. These are classified in…

CertaraMarch 3, 2023

Blog

Common Clinical Trial Disclosure Challenges & Potential Solutions

Pharmaceutical companies are being required to be more transparent through the timely disclosure of more…

CertaraFebruary 24, 2023

Blog

Artificial Intelligence: What is it & how can it accelerate rare disease drug development?

Large & complex information streams present opportunities for the AI data scientist to aid in…

CertaraFebruary 3, 2023

Blog

Will the Inflation Reduction Act Impact Drug Development Decisions?

The short answer is yes. In fact, passage of the Inflation Reduction Act (H.R. 5376)…

CertaraJanuary 27, 2023

Blog

Tips & Tricks for Streamlining Non-compartmental Pharmacokinetic Analysis

These Phoenix tips and tricks will help you exclude Lambda Z, name partial areas, and…

CertaraJanuary 20, 2023

Blog

Innovating Sales & Marketing Digital Engagement for Pharma and Med Tech

Stepwise PIPs: A Solution for the Challenges of Pediatric Drug Development

Considerations for Pricing & Formulary Access for DRG-Funded Hospital Drugs

Tips & Tricks for Optimizing Your Pharmacokinetic Modeling & Simulation

Leveraging AI to Accelerate Drug Discovery: Vyasa Joins Certara

Drug Development Considerations for Live Biotherapeutic Products

Common Clinical Trial Disclosure Challenges & Potential Solutions

Artificial Intelligence: What is it & how can it accelerate rare disease drug development?

Will the Inflation Reduction Act Impact Drug Development Decisions?

Tips & Tricks for Streamlining Non-compartmental Pharmacokinetic Analysis

Newsletter sign up

Quick links

Solutions

Contact